The -Omics in drug development
| Contribuinte(s) |
Bonate, P.L. Howard, D.R |
|---|---|
| Data(s) |
2011
|
| Resumo |
New advancement in genomics, proteomics, and metabonomics created significant excitement about the use of these relatively new technologies in drug design, discovery, development, and molecular-targeted therapeutics by identifying new drug targets and better tools for safety and efficacy studies in preclinical and clinical stages of drug development as well as diagnostics. In this chapter, we will briefly discuss the application of genomics, proteomics, and metabonomics in drug discovery and development |
| Identificador | |
| Publicador |
Springer |
| Relação |
http://download.springer.com/static/pdf/551/chp%253A10.1007%252F978-1-4419-7937-7_7.pdf?auth66=1405122877_90f008cc24f5247dbbee972187bf21a6&ext=.pdf DOI:10.1007/978-1-4419-7937-7_7 Moridani, Majid Y., Araujo, Robyn P., Johnson, Caroline H., & Lindon, John C. (2011) The -Omics in drug development. In Bonate, P.L. & Howard, D.R (Eds.) Pharmacokinetics in Drug Development : Volume 3 : Advances and Applications. Springer, pp. 145-173. |
| Fonte |
Faculty of Science and Technology; Institute of Health and Biomedical Innovation; School of Mathematical Sciences |
| Palavras-Chave | #010000 MATHEMATICAL SCIENCES #020000 PHYSICAL SCIENCES #060000 BIOLOGICAL SCIENCES #110000 MEDICAL AND HEALTH SCIENCES #111500 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES #111503 Clinical Pharmacy and Pharmacy Practice #Pharmacokinetics #Pharmaceuticals |
| Tipo |
Book Chapter |
